Management Protocols of stable coronary artery disease in India: Executive summary.
作者信息
Mishra Sundeep, Ray Saumitra, Dalal Jamshed J, Sawhney J P S, Ramakrishnan S, Nair Tiny, Iyengar S S, Bahl Vinay K
机构信息
Department of Cardiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
AMRI Hospital, Kolkata, India.
出版信息
Indian Heart J. 2016 Nov-Dec;68(6):868-873. doi: 10.1016/j.ihj.2016.11.318.
Abstract
摘要
相似文献
1
Management Protocols of stable coronary artery disease in India: Executive summary.
Indian Heart J. 2016 Nov-Dec;68(6):868-873. doi: 10.1016/j.ihj.2016.11.318.
2
Prevalence, treatments and outcomes of coronary artery disease in Indians: A systematic review.
Indian Heart J. 2015 Jul-Aug;67(4):302-10. doi: 10.1016/j.ihj.2015.05.003. Epub 2015 Jul 10.
3
Coronary artery disease and its problems in management.
J Indian Med Assoc. 2001 Sep;99(9):474-5.
4
Stable coronary artery disease.
Hellenic J Cardiol. 2014 Mar-Apr;55(2):175-7.
5
Prevalence of metabolic syndrome in patients with angiographically proven coronary artery disease presenting to a tertiary care hospital in Delhi, India.
Diabetes Metab Syndr. 2011 Apr-Jun;5(2):53-60. doi: 10.1016/j.dsx.2010.12.008. Epub 2011 Feb 4.
6
Multisite artery disease: a common and challenging clinical condition calling for specific management.
Future Cardiol. 2014 May;10(3):395-407. doi: 10.2217/fca.14.25.
7
Prevalence of coronary artery disease in India.
Indian Heart J. 2002 Jan-Feb;54(1):103.
8
Unique Aspects of Coronary Artery Disease in Indian Women.
Cardiovasc Drugs Ther. 2015 Aug;29(4):369-76. doi: 10.1007/s10557-015-6594-5.
9
Coronary artery disease in India.
J Indian Med Assoc. 2009 Sep;107(9):614-6.
10
Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease.
Int J Cardiol. 2013 Sep 10;167(6):2938-43. doi: 10.1016/j.ijcard.2012.08.013. Epub 2012 Sep 15.
引用本文的文献
1
Diabetes-Kidney-Heart Continuum and Its Implication on Therapeutic Management.
Cureus. 2025 Jul 22;17(7):e88561. doi: 10.7759/cureus.88561. eCollection 2025 Jul.
2
Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians.
Diabetes Ther. 2019 Apr;10(2):393-428. doi: 10.1007/s13300-019-0562-1. Epub 2019 Jan 31.
3
Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus - International Task Force.
Indian J Endocrinol Metab. 2018 Jan-Feb;22(1):132-157. doi: 10.4103/ijem.IJEM_556_17.
4
Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure.
Indian Heart J. 2017 May-Jun;69(3):393-401. doi: 10.1016/j.ihj.2017.04.001. Epub 2017 Apr 29.
5
Management standards for stable coronary artery disease in India.
Indian Heart J. 2016 Dec;68 Suppl 3(Suppl 3):S31-S49. doi: 10.1016/j.ihj.2016.11.320. Epub 2016 Dec 9.
本文引用的文献
1
Vascular Disease in Young Indians (20-40 years): Role of Ischemic Heart Disease.
J Clin Diagn Res. 2016 Sep;10(9):OE08-OE12. doi: 10.7860/JCDR/2016/20206.8517. Epub 2016 Sep 1.
2
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
3
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
N Engl J Med. 2016 Mar 17;374(11):1094. doi: 10.1056/NEJMc1600827.
4
Does modern medicine increase life-expectancy: Quest for the Moon Rabbit?
Indian Heart J. 2016 Jan-Feb;68(1):19-27. doi: 10.1016/j.ihj.2016.01.003. Epub 2016 Jan 18.
5
Meta-analysis of the association between second-hand smoke exposure and ischaemic heart diseases, COPD and stroke.
BMC Public Health. 2015 Dec 1;15:1202. doi: 10.1186/s12889-015-2489-4.
6
Short-Term Effects of Verapamil and Diltiazem in the Treatment of No Reflow Phenomenon: A Meta-Analysis of Randomized Controlled Trials.
Biomed Res Int. 2015;2015:382086. doi: 10.1155/2015/382086. Epub 2015 Oct 4.
7
Coronary microvascular dysfunction, microvascular angina, and treatment strategies.
JACC Cardiovasc Imaging. 2015 Feb;8(2):210-20. doi: 10.1016/j.jcmg.2014.12.008.
8
Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention.
J Interv Cardiol. 2014 Oct;27(5):472-81. doi: 10.1111/joic.12142. Epub 2014 Aug 30.
9
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease.
Can J Cardiol. 2014 Aug;30(8):837-49. doi: 10.1016/j.cjca.2014.05.013. Epub 2014 May 28.
10
Cardiovascular disease risk factors in Asian Indian population: A systematic review.
J Cardiovasc Dis Res. 2013 Dec;4(4):222-8. doi: 10.1016/j.jcdr.2014.01.004. Epub 2014 Feb 18.
Zotero 插件